V-Ferin Probiotic Supplement For Vaginal Infections

Hyderabad (Telangana) [India], November 25: Lee Health Domain, a Hyderabad based pharmaceutical company launches “V-Ferin”, a probiotic supplement for vaginal infections. Formulated with novel compounds of the pre & probiotics lactobacillus acidophilus with synergetic effect of Lactoferrin peptide and cranberry fruit extract specifically to support and improve health, restore the natural microbiome, and prevent vaginal infections.

According to the WHO (World Health Organization), a significant percentage of women (around 25–30%) experience some form of vaginal infection during their lives, with bacterial vaginosis and yeast infections being the most frequent.

These infections can cause discomfort, disrupt daily life, and, if left untreated, lead to more serious complications such as pelvic inflammatory disease or fertility issues, Says A. Leela Rani, Director, Lee Health Domain.

Unlike traditional treatments that may only address the symptoms of vaginal infections, V-Ferin takes a holistic approach by targeting the root causes of vaginal imbalances. It is a natural, drug-free solution that works in harmony with your body’s own defense mechanisms with its carefully selected ingredients.

V-Ferin is free from artificial additives, preservatives, and harsh chemicals, making it a safe and gentle option for all women. V-Ferin is the ideal choice for women to maintain a healthy, balanced vaginal microbiome—naturally.

In a world where women’s health is often subject to a range of challenges, vaginal infections remain one of the most common and persistent concerns. However, emerging research and innovation in the field of nutraceuticals—natural products that promote health and wellness—offer a new, effective solution to these problems.

The V-Ferin made available in all pharmacies and through online websites https://www.leehealthdomain.com and Amazon.

Disclaimer: The article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

Health

TRANSFORM II Trial Hits Enrollment Milestone: Redefining Coronary Care with Sirolimus-Coated Balloons

New Delhi [India], June 14: The Fondazione Ricerca e Innovazione Cardiovascolare (RIC) has successfully finished patient enrolment for TRANSFORM II, one of the most ambitious and extensive randomised controlled trials (RCTs) ever carried out in the field of cardiovascular care, at a pivotal point for the future of interventional cardiology.  In order to treat de-novo […]

Read More
Health

Introducing Hidoc Dr KOL Factory The Future Hub for Oncology Leaders Worldwide

New Delhi [India], June 13: In oncology, seamless collaboration is essential; yet, connecting with the right experts across countries remains slow, fragmented, and often challenging. Geographic barriers, unverified profiles, and closed networks create obstacles that delay vital partnerships between oncologists and pharma, slowing research, innovation, and progress in patient care. This is exactly where Hidoc […]

Read More
Health

Daradia Launches India’s First Web MSK Ultrasound Simulator for Pain Intervention Training

Kolkata (West Bengal) [India], June 5: In a significant advancement in medical training, Daradia: The Pain Clinic, a Kolkata-based institution known for its pioneering work in interventional pain medicine, has launched India’s first web-based musculoskeletal (MSK) ultrasound simulator. This cutting-edge digital platform is designed to train doctors in MSK sonoanatomy—an essential skill for performing ultrasound-guided pain […]

Read More